FutureNeuro and GreenLight Medicines partner to develop treatments for epilepsy

(RCSI) A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug resistant epilepsies, and in particular, childhood epilepsies.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news